EULAR 2024 Highlights: Day 4

EULAR 2024 Highlights: Day 3

EULAR 2024 Highlights: Day 2

EULAR 2024 Highlights: Day 1

EULAR 2024 Preview Podcast

Discussing RA: May 2024

PsA Podcast: Bimekizumab therapy in PsA

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024

IMID Author Interview: Dorthe Berthelsen, 2024

AxSpA Podcast: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar

Webinar Highlights Podcast: Evolving Therapeutic Strategies for Psoriatic Diseases

IMID Author Interview: Dr Jake Weddell, 2024

PsA Podcast: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

IMID Author Interview: Professor Frank Verhoeven, 2024

Discussing RA: April 2024

Author Interview: Professor Maria Antonietta D’Agostino, 2024

Author Interview: Professor Dennis McGonagle, 2024

AxSpA Podcast: Secukinumab retention over time & sacroiliac joint improvements between DMARDs

Author Interview: Dr Jürgen Rech, 2024

PsA Podcast: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population

Discussing Rheumatology: March 2024

AxSpA Podcast: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

Discussing Rheumatology: February 2024

PsA Podcast: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs

Author Interview: Dr Mahta Mortezavi, 2024

Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs

Author Interview: Dr Kehinde Sunmboye, 2024

Discussing Rheumatology: January 2024

AxSpA Podcast: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice